Search details
1.
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet
; 403(10445): 2720-2731, 2024 Jun 22.
Article
in English
| MEDLINE | ID: mdl-38824941
2.
Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity.
Mol Ther
; 32(2): 411-425, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38098229
3.
BL-B01D1, a first-in-class EGFR-HER3 bispecific antibody-drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study.
Lancet Oncol
; 2024 May 29.
Article
in English
| MEDLINE | ID: mdl-38823410
4.
Induction of therapeutic immunity and cancer eradication through biofunctionalized liposome-like nanovesicles derived from irradiated-cancer cells.
J Nanobiotechnology
; 22(1): 156, 2024 Apr 08.
Article
in English
| MEDLINE | ID: mdl-38589867
5.
Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial.
BMC Cancer
; 23(1): 249, 2023 Mar 15.
Article
in English
| MEDLINE | ID: mdl-36922805
6.
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
JAMA
; 330(20): 1961-1970, 2023 11 28.
Article
in English
| MEDLINE | ID: mdl-38015220
7.
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Lancet
; 398(10297): 303-313, 2021 07 24.
Article
in English
| MEDLINE | ID: mdl-34111416
8.
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.
N Engl J Med
; 381(12): 1124-1135, 2019 09 19.
Article
in English
| MEDLINE | ID: mdl-31150573
9.
Characteristics of older-patient-specif ic oncological trials: a cross-sectional analysis of ClinicalTrials.gov.
Age Ageing
; 51(4)2022 04 01.
Article
in English
| MEDLINE | ID: mdl-35429270
10.
Self-adjuvanting cancer nanovaccines.
J Nanobiotechnology
; 20(1): 345, 2022 Jul 26.
Article
in English
| MEDLINE | ID: mdl-35883176
11.
Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research.
J Nanobiotechnology
; 20(1): 189, 2022 Apr 13.
Article
in English
| MEDLINE | ID: mdl-35418077
12.
A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study.
Eur J Nucl Med Mol Imaging
; 48(10): 3228-3237, 2021 09.
Article
in English
| MEDLINE | ID: mdl-33609152
13.
Translation and cross-cultural adaption of the Chinese version of the Vanderbilt Head and Neck Symptom Survey version 2.0: a tool for oral symptom assessment in head and neck cancer patients.
Health Qual Life Outcomes
; 19(1): 27, 2021 Jan 21.
Article
in English
| MEDLINE | ID: mdl-33478530
14.
Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Lancet Oncol
; 21(7): 904-913, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32479787
15.
Elevations of serum cancer biomarkers correlate with severity of COVID-19.
J Med Virol
; 92(10): 2036-2041, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32347972
16.
Proteomic analysis of the human cyclin-dependent kinase family reveals a novel CDK5 complex involved in cell growth and migration.
Mol Cell Proteomics
; 13(11): 2986-3000, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25096995
17.
Risk factors for in-hospital mortality in patients with cancer and COVID-19 - Authors' reply.
Lancet Oncol
; 21(9): e408, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32888458
18.
Antitumor activity of SAHA, a novel histone deacetylase inhibitor, against murine B cell lymphoma A20 cells in vitro and in vivo.
Tumour Biol
; 36(7): 5051-61, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25649979
19.
Magnetic nanoparticle clusters radiosensitise human nasopharyngeal and lung cancer cells after alternating magnetic field treatment.
Int J Hyperthermia
; 31(7): 800-12, 2015.
Article
in English
| MEDLINE | ID: mdl-26382714
20.
Risk factors of complications after CT-guided percutaneous needle biopsy of lumps near pulmonary hilum.
J Huazhong Univ Sci Technolog Med Sci
; 35(2): 278-282, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25877365